Xtacy Therapeutics (XTCYF, $0.05) was a top weekly loser, falling to $0.05 per share. Of the 163 stocks analyzed in the Finance/Rental/Leasing Industry throughout the week of May 29 - June 5, of them (7) exhibited an Uptrend while of them (2) were in a Downtrend.